Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biora Therapeutics Q4 EPS $(0.63) Misses $(0.59) Estimate

Author: Benzinga Newsdesk | March 26, 2024 04:42pm
Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.59) by 6.78 percent. This is a 60.87 percent increase over losses of $(1.61) per share from the same period last year.

Posted In: BIOR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist